These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8821695)

  • 1. Antitumoral local effect and metastatic risk of focused extracorporeal pyrotherapy on Dunning R-3327 tumors.
    Bataille N; Vallancien G; Chopin D
    Eur Urol; 1996; 29(1):72-7. PubMed ID: 8821695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327.
    Chapelon JY; Margonari J; Vernier F; Gorry F; Ecochard R; Gelet A
    Cancer Res; 1992 Nov; 52(22):6353-7. PubMed ID: 1423282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor ablation with focalized ultrasound. In vivo experiment with prostatic adenocarcinoma R3327 Mat-Ly-Lu].
    Margonari J; Chapelon JY; Gelet A; Cathignol D; Bouvier R; Gorry F
    Prog Urol; 1992 Apr; 2(2):207-19. PubMed ID: 1302056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of high-intensity focused ultrasound on the development of metastases.
    Oosterhof GO; Cornel EB; Smits GA; Debruyne FM; Schalken JA
    Eur Urol; 1997; 32(1):91-5. PubMed ID: 9266238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of high-energy shock waves on the development of metastases.
    Oosterhof GO; Cornel EB; Smits GA; Debruyne FM; Schalken JA
    Ultrasound Med Biol; 1996; 22(3):339-44. PubMed ID: 8783466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between tumor size and the curability of metastatic prostatic cancer by surgery alone or in combination with adjuvant chemotherapy.
    Henry JM; Isaacs JT
    J Urol; 1988 May; 139(5):1119-23. PubMed ID: 3361656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT; Yu GW; Coffey DS
    Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA; Gladu J
    Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
    Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
    Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused extracorporeal pyrotherapy.
    Vallancien G; Chartier-Kastler E; Bataille N; Chopin D; Harouni M; Bougaran J
    Eur Urol; 1993; 23 Suppl 1():48-52. PubMed ID: 7685697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
    Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A
    J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy.
    Vallancien G; Harouni M; Guillonneau B; Veillon B; Bougaran J
    Urology; 1996 Feb; 47(2):204-7. PubMed ID: 8607235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic placement of the Dunning R3327 AT-3 prostate tumor in the Copenhagen X Fischer rat.
    Rubenstein M; Saffrin R; Shaw M; Muchnik S; Guinan P
    Prostate; 1995 Sep; 27(3):148-53. PubMed ID: 7567693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
    Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction of ultrasonic shock waves and hyperthermia in the Dunning prostate tumor R3327-AT1.
    Huber P; Peschke P; Brix G; Hahn EW; Lorenz A; Tiefenbacher U; Wannenmacher M; Debus J
    Int J Cancer; 1999 Jul; 82(1):84-91. PubMed ID: 10360825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumor.
    Kadmon D; Heston WD; Fair WR
    Prostate; 1981; 2(3):299-307. PubMed ID: 7301657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA; Harakidas P; Bowlin T; Attardo G
    Cancer Res; 1998 Aug; 58(15):3461-5. PubMed ID: 9699681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.